Addus HomeCare (NASDAQ:ADUS) EVP Cliff Donald Blessing Sells 177 Shares

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Cliff Donald Blessing sold 177 shares of the firm’s stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total value of $18,648.72. Following the transaction, the executive vice president owned 12,361 shares in the company, valued at approximately $1,302,354.96. The trade was a 1.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Cliff Donald Blessing also recently made the following trade(s):

• On Tuesday, February 24th, Cliff Donald Blessing sold 350 shares of Addus HomeCare stock. The shares were sold at an average price of $107.14, for a total transaction of $37,499.00.

Addus HomeCare Trading Down 3.3%

ADUS stock traded down $3.58 on Thursday, reaching $104.02. The company’s stock had a trading volume of 269,378 shares, compared to its average volume of 239,147. The business has a fifty day simple moving average of $109.57 and a two-hundred day simple moving average of $113.08. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $124.43. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.66 and a current ratio of 1.80. The firm has a market cap of $1.92 billion, a PE ratio of 19.97, a PEG ratio of 1.26 and a beta of 0.91.

Addus HomeCare News Summary

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&A-driven growth strategy for 2026 — supports longer‑term earnings upside. Addus HomeCare Earnings Call Highlights Growth And Scale
• Positive Sentiment: Stephens trimmed its price target from $140 to $135 but kept an “overweight” rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. Stephens price target note
• Neutral Sentiment: Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). Conference participation
• Neutral Sentiment: Some published short‑interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. MarketBeat ADUS page
• Negative Sentiment: Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre‑planned. See CEO filing. CEO insider-sale SEC filing
• Negative Sentiment: Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days‑to‑cover) — elevated short activity can amplify downward price moves. Short interest data

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday. Barclays dropped their price target on shares of Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating on the stock in a report on Tuesday. Wall Street Zen raised shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Monday. Finally, Truist Financial set a $135.00 price objective on shares of Addus HomeCare and gave the company a “buy” rating in a research report on Wednesday, January 7th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $134.33.

Institutional Trading of Addus HomeCare

Several large investors have recently added to or reduced their stakes in ADUS. Global Retirement Partners LLC boosted its stake in shares of Addus HomeCare by 395.7% during the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after acquiring an additional 186 shares during the last quarter. Larson Financial Group LLC raised its holdings in Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares during the period. Acumen Wealth Advisors LLC purchased a new position in Addus HomeCare during the fourth quarter valued at $29,000. Arax Advisory Partners lifted its position in Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after purchasing an additional 137 shares in the last quarter. Finally, Private Trust Co. NA grew its holdings in Addus HomeCare by 65.5% during the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock valued at $30,000 after purchasing an additional 112 shares during the period. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.